{"id":"https://openalex.org/W2600898673","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7557","title":"Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigator\u2019s choice chemotherapy following progression on afatinib monotherapy.","display_name":"Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigator\u2019s choice chemotherapy following progression on afatinib monotherapy.","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2600898673","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7557","mag":"2600898673"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.7557","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7557","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.7557","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036507802","display_name":"Martin Sch\u00fcler","orcid":"https://orcid.org/0000-0002-2166-3394","observed_orcids":["https://orcid.org/0000-0002-2166-3394"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin H. Schuler","raw_affiliation_strings":["Department of Medical Oncology, West German Cancer Center, University Duisburg-Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, West German Cancer Center, University Duisburg-Essen, Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028596081","display_name":"David Planchard","orcid":"https://orcid.org/0000-0002-1565-8310","observed_orcids":["https://orcid.org/0000-0002-1565-8310"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"David Planchard","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055074037","display_name":"James Chih\u2010Hsin Yang","orcid":"https://orcid.org/0000-0002-5586-5138","observed_orcids":["https://orcid.org/0000-0002-5586-5138"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"James Chih-Hsin Yang","raw_affiliation_strings":["National Taiwan University Hospital, Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital, Taipei, Taiwan","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005188570","display_name":"Joo-Hang Kim","orcid":"https://orcid.org/0000-0003-0408-8997","observed_orcids":["https://orcid.org/0000-0003-0408-8997"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Joo-Hang Kim","raw_affiliation_strings":["Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003664573","display_name":"Filippo de Marinis","orcid":"https://orcid.org/0000-0002-1118-5536","observed_orcids":["https://orcid.org/0000-0002-1118-5536"]},"institutions":[{"id":"https://openalex.org/I4210095143","display_name":"Azienda Ospedaliera San Camillo-Forlanini","ror":"https://ror.org/00j707644","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210095143"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo De Marinis","raw_affiliation_strings":["San Camillo and Forlanini Hospital, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Camillo and Forlanini Hospital, Rome, Italy","institution_ids":["https://openalex.org/I4210095143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028055906","display_name":"Yuh\u2010Min Chen","orcid":"https://orcid.org/0000-0003-0585-8463","observed_orcids":["https://orcid.org/0000-0003-0585-8463"]},"institutions":[{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Yuh-Min Chen","raw_affiliation_strings":["Taipei Veterans General Hospital, Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taipei Veterans General Hospital, Taipei, Taiwan","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024628268","display_name":"Caicun Zhou","orcid":"https://orcid.org/0000-0002-6958-0766","observed_orcids":["https://orcid.org/0000-0002-6958-0766","https://orcid.org/0000-0002-1072-9941"]},"institutions":[{"id":"https://openalex.org/I4210127126","display_name":"Shanghai Pulmonary Hospital","ror":"https://ror.org/033nbnf69","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210127126"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Caicun Zhou","raw_affiliation_strings":["Shanghai Pulmonary Hospital, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Pulmonary Hospital, Shanghai, China","institution_ids":["https://openalex.org/I4210127126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030078141","display_name":"Jaafar Bennouna","orcid":"https://orcid.org/0000-0002-5034-1108","observed_orcids":["https://orcid.org/0000-0002-5034-1108"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaafar Bennouna","raw_affiliation_strings":["Centre Ren\u00e9 Gauducheau, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Ren\u00e9 Gauducheau, Nantes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109417430","display_name":"Xiaoqing Liu","orcid":"https://orcid.org/0009-0004-4457-0926","observed_orcids":["https://orcid.org/0009-0004-4457-0926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoqing Liu","raw_affiliation_strings":["Hospital of PLA, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital of PLA, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102745348","display_name":"J. Feng","orcid":"https://orcid.org/0000-0003-2805-6818","observed_orcids":["https://orcid.org/0000-0003-2805-6818"]},"institutions":[{"id":"https://openalex.org/I4210128482","display_name":"Jiangsu Cancer Hospital","ror":"https://ror.org/03108sf43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210128482"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ji Feng Feng","raw_affiliation_strings":["Jiangsu Cancer Hospital, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Cancer Hospital, Nanjing, China","institution_ids":["https://openalex.org/I4210128482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089891961","display_name":"Paolo Bidoli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Bidoli","raw_affiliation_strings":["S. Gerardo Hospital, Monza, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Gerardo Hospital, Monza, Italy","institution_ids":["https://openalex.org/I4210110840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038943836","display_name":"J\u00e1nos Strausz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163183","display_name":"Orsz\u00e1gos Kor\u00e1nyi Tbc \u00e9s Pulmonol\u00f3giai Int\u00e9zet","ror":"https://ror.org/051mrhb02","country_code":"HU","type":"facility","lineage":["https://openalex.org/I4210163183"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Janos Strausz","raw_affiliation_strings":["Koranyi National Institute for Pulmonology, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koranyi National Institute for Pulmonology, Budapest, Hungary","institution_ids":["https://openalex.org/I4210163183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087923582","display_name":"Sai\u2010Hong Ignatius Ou","orcid":"https://orcid.org/0000-0002-1764-4975","observed_orcids":["https://orcid.org/0000-0002-1764-4975"]},"institutions":[{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sai-Hong Ignatius Ou","raw_affiliation_strings":["Chao Family Comprehensive Cancer Center, Orange, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chao Family Comprehensive Cancer Center, Orange, CA","institution_ids":["https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063821551","display_name":"Vikram K. Chand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vikram K. Chand","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086847475","display_name":"Bushi Wang","orcid":"https://orcid.org/0000-0001-8916-9416","observed_orcids":["https://orcid.org/0000-0001-8916-9416"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bushi Wang","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009835812","display_name":"Gerd Michael Munzert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerd Michael Munzert","raw_affiliation_strings":["Boehringer Ingelheim, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030107272","display_name":"Keunchil Park","orcid":"https://orcid.org/0000-0002-4846-7449","observed_orcids":["https://orcid.org/0000-0002-4846-7449"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Keunchil Park","raw_affiliation_strings":["Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":16,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"7557","last_page":"7557"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.984000027179718},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.8730000257492065},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8050000071525574},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.652999997138977},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6060000061988831},{"id":"https://openalex.org/keywords/erbb4","display_name":"ErbB4","score":0.6819999814033508},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.777999997138977},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.949999988079071},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.5189999938011169},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.47099998593330383},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.35499998927116394},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.5379999876022339},{"id":"https://openalex.org/keywords/egfr-mutation-testing","display_name":"EGFR mutation testing","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.9701197147369385},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9175466299057007},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7064606547355652},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6891209483146667},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.6119349002838135},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6107287406921387},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.5854777693748474},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5163963437080383},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.4723281264305115},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4539298117160797},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.42840200662612915},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4091576337814331},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3354133665561676},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28844988346099854},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.21205541491508484}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.7557","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7557","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.7557","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2957137166","https://openalex.org/W2607223419","https://openalex.org/W2132540363","https://openalex.org/W2275139067","https://openalex.org/W2122489831","https://openalex.org/W2599969362","https://openalex.org/W2947905396","https://openalex.org/W2612476467","https://openalex.org/W2626422495","https://openalex.org/W2408182535"],"abstract_inverted_index":{"7557":[0],"Background:":[1],"The":[2,164,260],"benefit":[3,89,288],"of":[4,27,69,141],"sustained":[5],"ErbB":[6,313],"family":[7],"blockade":[8],"in":[9,37,289],"NSCLC":[10,65,293],"patients":[11,38,86,160,202,217,231,277],"with":[12,39,59,87,246],"acquired":[13],"resistance":[14],"(AR)":[15],"to":[16,94,156,181,296,304],"EGFR":[17,28,129,214,228,305],"TKIs":[18,306],"is":[19,147],"unknown.":[20],"We":[21],"investigated":[22],"afatinib,":[23],"an":[24,205],"irreversible":[25],"blocker":[26],"(ErbB1),":[29],"HER2":[30],"(ErbB2)":[31],"and":[32,46,191,270],"ErbB4":[33],"receptor":[34],"tyrosine":[35],"kinases,":[36],"metastatic":[40,64],"NSCLC,":[41],"who":[42,71],"had":[43,166,211],"failed":[44,72],"chemotherapy":[45,70,105],"E/G.":[47],"Methods:":[48],"This":[49],"was":[50,113,184,198,222,241],"a":[51,285],"Phase":[52],"III,":[53],"randomized,":[54],"open-label,":[55],"multi-center":[56],"trial.":[57],"Patients":[58],"pathologically":[60],"confirmed":[61],"Stage":[62],"IIIB/IV":[63],"after":[66],"\u22651":[67],"line":[68],"E/G":[73,183],"received":[74,161],"oral":[75],"afatinib":[76,96,145,162,197],"50":[77],"mg":[78,98],"until":[79],"disease":[80,309],"progression":[81],"(Part":[82,106],"A).":[83],"After":[84],"progression,":[85],"clinical":[88,235],"(\u226512":[90],"wks)":[91],"were":[92,125,135,170,173,176,267],"eligible":[93],"continue":[95],"40":[97],"plus":[99],"paclitaxel":[100],"or":[101],"receive":[102],"investigator\u2019s":[103],"choice":[104],"B).":[107],"Primary":[108],"endpoint":[109],"for":[110,127,196,227,238,244,252,302],"Part":[111,142,150,274],"A":[112,151],"PFS":[114,195,221,240],"(RECIST":[115],"1.1;":[116],"CT":[117],"scan":[118],"every":[119],"6":[120],"wks).":[121],"Available":[122],"tumor":[123,207],"samples":[124],"collected":[126],"central":[128],"mutation":[130,133,215,229],"testing;":[131],"local":[132],"data":[134],"also":[136],"collected.":[137],"An":[138],"interim":[139],"analysis":[140],"A,":[143,275],"assessing":[144],"monotherapy,":[146],"reported.":[148],"Results:":[149],"enrolled":[152],"April":[153],"2010":[154],"through":[155],"May":[157],"2011;":[158],"1154":[159],"monotherapy.":[163],"majority":[165],"adenocarcinoma":[167],"(85%),":[168],"57%":[169],"female,":[171],"43%":[172],"Asian,":[174],"54%":[175],"never":[177],"smokers.":[178],"Best":[179],"response":[180],"prior":[182],"CR":[185],"(2%),":[186],"PR":[187],"(31%),":[188],"SD":[189],"(42%)":[190],"PD":[192],"(20%).":[193],"Median":[194],"3.3":[199],"mths;":[200],"88":[201],"(8%)":[203],"achieved":[204,307],"objective":[206],"response,":[208],"648":[209],"(56%)":[210],"SD.":[212],"For":[213],"positive":[216],"(n=49,":[218],"centrally":[219],"confirmed),":[220],"4.2":[223,242],"vs.":[224,249],"2.6":[225],"mths":[226,243,251],"negative":[230],"(n=35).":[232],"When":[233],"applying":[234],"enrichment":[236,247],"criteria":[237],"AR,":[239],"those":[245,253],"(n=597)":[248],"2.8":[250],"without":[254],"(n=":[255],"557;":[256],"logrank":[257],"test":[258],"p<0.0001).":[259],"most":[261],"common":[262],"grade":[263],"3/4":[264],"adverse":[265],"events":[266],"diarrhea":[268],"(17%)":[269],"rash/acne":[271],"(11%).":[272],"In":[273],"99":[276],"remain":[278],"on":[279],"treatment.":[280],"Conclusions:":[281],"Afatinib":[282],"monotherapy":[283],"provided":[284],"clinically":[286,300],"meaningful":[287],"this":[290],"large,":[291],"treatment-refractory":[292],"trial,":[294],"similar":[295],"LUX-Lung":[297],"1.":[298],"Those":[299],"enriched":[301],"AR":[303],"prolonged":[308],"control":[310],"upon":[311],"continued":[312],"blockade.":[314]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":5}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-04-07T00:00:00"}